Skip to main content

Development of a safe, efficacious bluetongue virus vaccination strategy for europe (BLUETONGUE VACCINATION)

Objective

Bluetongue virus (BTV) has a track record of incursion into the EU & causing severe disease & financial losses to our livestock industry. However, the EU has no coherent vaccination policy, which makes BTV incursions difficult or impossible to control. This project will enable an effective policy to be established for the first time by testing the existing live virus vaccines for efficacy & safety, & by providing clear science-based recommendations on their use or otherwise in Europe. The project will also seek to develop & produce inactivated vaccines conferring enhanced protection using state of the art technology with engineered "virus-like particles" & slow release delivery systems. In addition, by sequencing live vaccine strains of BTV & wild strains isolated in the field around Europe, database will be established to enable sourcing of European BTV incursions & early detection of vaccine breakdown thus facilitating targeting of control measures.

Funding Scheme

CSC - Cost-sharing contracts

Coordinator

INSTITUTE FOR ANIMAL HEALTH
Address
Ash Road, Nr Woking
GU24 0NF Woking
United Kingdom

Participants (4)

AGRICULTURAL RESEARCH COUNCIL
South Africa
Address
X055,old Soutpan Road, Private Bag X5
0110 Pretoria
LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE
United Kingdom
Address
Keppel Street
WC1E 7HT London
MERIAL LIMITED
United Kingdom
Address
Kinghtsbridge 27
SW1 7QT London
THE SCHOOL OF PHARMACY, UNIVERSITY OF LONDON
United Kingdom
Address
Brunswick Square 29-39
WC1N 1AX London